These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2441448)

  • 81. [Interferon and therapy of oncological diseases].
    Andzhaparidze OG; Pille ER
    Vopr Virusol; 1989; 34(5):517-23. PubMed ID: 2481902
    [No Abstract]   [Full Text] [Related]  

  • 82. Chemotherapy of the malignant lymphomas and leukemias.
    GAMBLE JF
    Med Ann Dist Columbia; 1962 Apr; 31():195-9. PubMed ID: 13896557
    [No Abstract]   [Full Text] [Related]  

  • 83. Future prospects in lymphoma and leukemia.
    Holland JF
    Cancer; 1978 Aug; 42(2 Suppl):1035-8. PubMed ID: 688175
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Gene therapy for leukemia and lymphoma.
    Adams SW; Emerson SG
    Hematol Oncol Clin North Am; 1998 Jun; 12(3):631-48. PubMed ID: 9684102
    [TBL] [Abstract][Full Text] [Related]  

  • 85. 6th International Symposium and expert workshops on Leukemia and Lymphoma. 17-19 March, 2005, Amsterdam, The Netherlands.
    Kaspers GJ
    Expert Rev Anticancer Ther; 2005 Jun; 5(3):415-7. PubMed ID: 16001949
    [No Abstract]   [Full Text] [Related]  

  • 86. First Person: Clara Bloomfield, MD.
    Cancer; 2017 Feb; 123(3):369-370. PubMed ID: 28112818
    [No Abstract]   [Full Text] [Related]  

  • 87. Cyclophosphamide therapy. Its use in leukemia, lymphoma and solid tumors.
    WALL RL; CONRAD FG
    Arch Intern Med; 1961 Sep; 108():456-82. PubMed ID: 13782776
    [No Abstract]   [Full Text] [Related]  

  • 88. Targets for specific therapies in leukemia.
    Clarkson B; Chabner BA; Weinberg RA
    Cancer Res; 1995 Oct; 55(19):4488-98. PubMed ID: 7545542
    [No Abstract]   [Full Text] [Related]  

  • 89. Genetics and epigenetics of leukemia and lymphoma: from knowledge to applications, meeting report of the Josep Carreras Leukaemia Research Institute.
    Parra M; Baptista MJ; Genescà E; Llinàs-Arias P; Esteller M
    Hematol Oncol; 2020 Oct; 38(4):432-438. PubMed ID: 32073154
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [Leukemia].
    Killmann SA
    Tandlaegebladet; 1969 May; 73(5):339-44. PubMed ID: 5259632
    [No Abstract]   [Full Text] [Related]  

  • 91. A new feature in Leukemia & Lymphoma: "Emerging drug profile".
    Gandhi V
    Leuk Lymphoma; 2013 Oct; 54(10):2131-2. PubMed ID: 24041378
    [No Abstract]   [Full Text] [Related]  

  • 92. Abstracts of the 5th International Symposium on Leukemia and Lymphoma. 12-15 March 2003. Amsterdam, The Netherlands.
    Leukemia; 2003 Mar; 17(3):657-74. PubMed ID: 12744232
    [No Abstract]   [Full Text] [Related]  

  • 93. Karyotypes in acute childhood leukemias may lose prognostic significance with more intensive and specific chemotherapy.
    Lampert F; Harbott J; Ritterbach J; Schellong G; Ritter J; Creutzig U; Riehm H; Reiter A
    Cancer Genet Cytogenet; 1991 Jul; 54(2):277-9. PubMed ID: 1884366
    [No Abstract]   [Full Text] [Related]  

  • 94. Introduction: leukemia and lymphoma.
    Powles R; McElwain T
    Semin Hematol; 1982 Jul; 19(3):153-4. PubMed ID: 7112133
    [No Abstract]   [Full Text] [Related]  

  • 95. Biological approaches to cancer therapy.
    Foon KA
    Haematol Blood Transfus; 1987; 31():103-9. PubMed ID: 2450814
    [No Abstract]   [Full Text] [Related]  

  • 96. The XVIII Symposium of the International Association for Comparative Research on Leukemia and Related Diseases (IACRLRD) on Leukemia and Lymphoma/Pathogenesis and Treatment/Molecular Aspects. Kyoto, Japan, 29 October - 3 November 1995.
    Leukemia; 1997 Apr; 11 Suppl 3():1-587. PubMed ID: 9244824
    [No Abstract]   [Full Text] [Related]  

  • 97. Patient education: chemotherapy and patient information.
    Davis C
    Nurs Stand; 1990 Mar 21-27; 4(26):25-7. PubMed ID: 2110301
    [No Abstract]   [Full Text] [Related]  

  • 98. [Fibroblast interferon therapy in patients with NHL of low-grade malignancy: preliminary results (author's transl)].
    Fink U; Siegert W; Huhn D; Wilmanns W; Berdel WE; Emmerich B; Hutsteiner H; Wüst I; Rastetter J; Theml H; Riethmüller G
    Blut; 1982 Feb; 44(2):121-4. PubMed ID: 6174164
    [No Abstract]   [Full Text] [Related]  

  • 99. [Oral aspects of leukemia].
    Holst E
    Tandlaegebladet; 1969 May; 73(5):345-50. PubMed ID: 5259633
    [No Abstract]   [Full Text] [Related]  

  • 100. ELTEC: ten years of activity (1990-2000)--a report of the International BFM Study Group.
    Jankovic M; Reciputo A; Haupt R; Micalizzi C; Manganini C; Frey E; Lackner H; Maurus R; Beck JD; Langer T; Marx M; Krappmann P; Magyarosy E; Feldges A; van Weel-Sipman M
    Med Pediatr Oncol; 2002 Feb; 38(2):124. PubMed ID: 11813180
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.